Skip to main content
OpenTrials
Completed

NCT Number: NCT04527497

Clinical Course and Treatment of COVID-19 Inpatients in Hospital

The study is an epidemiological observational study. It serves to collect data from patients with positive COVID-19 test results who are hospitalized. All data describing the course of the inpatient stay are recorded (Length of stay, course of therapy, medication, X-ray and CT results,ventilation mode and duration, laboratory). Furthermore, anthropometric data and information on COVID-19 symptoms is recorded.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.

Solingen, North Rhine-Westphalia, 42699, Germany

About this study

The aim of this study is to describe the course of disease and the treatment of patients suffering from COVID-19 who are hospitalized and treated as inpatients:

  • Are there common features (previous illnesses, medication, age, BMI, etc.), which may influence the course of disease?
  • Are there therapeutic procedures that have a positive or negative impact on the course of the disease or the length of stay in the intensive care unit/ the duration of ventilation (early/late intubation, CPAP, NIV, ECMO)?

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • positive COVID-19 test result
  • Age > 18 years

Exclusion criteria

  • Age < 18 years
  • negative COVID-19 test result
  • lack of agreement
  • Any medical, psychological or other condition, that restricts the ability of the person to be informed and to give the consent for voluntary participation in this trial

Treatment and study plan

Primary outcomes

  1. convalescence/death

    Time frame: through study completion, an average of 2 months

    has patient died or has patient recovered

Secondary outcomes

  1. length of stay in the intensive care unit

    Time frame: through study completion, an average of 2 months

    length of stay in the intensive care unit

  2. length of stay in hospital

    Time frame: through study completion, an average of 2 months

    length of stay in hospital

Sponsors and collaborators

Lead sponsor

Wissenschaftliches Institut Bethanien e.V

Other

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Aug 26, 2020
Registry last updated
Dec 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.